Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando
| Image |  |
|---|---|
| Description | scientific article published on 28 September 2014 |
| Author/s |
author: Javier Cortes Joseph Gligorov Michelino De Laurentiis Eva M Ciruelos Fabio Puglisi |
| Publication date | September 28, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |